Skip to main content
Erschienen in: Pediatric Cardiology 7/2014

01.10.2014 | Original Article

Predictive Value of Myocardial Delayed Enhancement in Duchenne Muscular Dystrophy

verfasst von: Shaji C. Menon, Susan P. Etheridge, Kirk N. Liesemer, Richard V. Williams, Tyler Bardsley, Mason C. Heywood, Michael D. Puchalski

Erschienen in: Pediatric Cardiology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

In other cardiomyopathies, cardiac magnetic resonance imaging (CMR)-derived myocardial delayed enhancement (MDE), a marker of myocardial fibrosis, is a risk factor for sudden cardiac death (SCD). In Duchenne muscular dystrophy (DMD), the prognostic value of MDE for ventricular arrhythmias and death is unknown. This study aimed to evaluate associations between MDE and electrocardiographic (ECG) changes, ventricular remodeling, risk of arrhythmias, and death in DMD. This retrospective study included all subjects with DMD who had undergone a CMR between January 2006 and December 2011 and had available ECG and 24-h Holter records from the same period. Left ventricular (LV) MDE was semiquantitatively graded from 0 to 4. Comparisons of demographic and clinical characteristics between MDE and no-MDE groups were made. Cox regression analysis was performed to assess factors associated with death. This study investigated 32 boys with a median age of 13.8 years (range, 7.2–17.4 years) and found MDE present in 25 (78 %) of the boys. Compared with the no-MDE subjects, the MDE subjects were older (15.7 ± 3.3 vs 12.1 ± 4.8 years) and had a wider QT dispersion (QTd: 74 ± 30 vs 55 ± 33 ms), a higher incidence of ventricular tachycardia (40 vs 0 %), a lower LV ejection fraction (46 ± 12 vs 56 ± 9 %), a larger LV end-diastolic volume (124 ± 58 vs 68 ± 14 ml/m2), and a larger end-systolic volume (57 ± 29 vs 28 ± 10 ml/m2) (p < 0.05 for all). During the study period, six of the subjects (19 %) died. The factors associated with mortality were increased age, advanced grade of MDE, higher LV end-systolic volume, lower LV ejection fraction, use of beta-blockers, and ventricular tachycardia. Myocardial fibrosis detected by CMR is an independent predictor of adverse cardiac remodeling, ventricular arrhythmias, and death in DMD. Cardiac MRI using MDE can be applied as a screening tool to detect patients at risk for ventricular arrhythmias, more advanced disease, adverse LV remodeling, and death.
Literatur
1.
Zurück zum Zitat Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369–1374. doi:10.1016/j.jacc.2007.11.071 CrossRefPubMed Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369–1374. doi:10.​1016/​j.​jacc.​2007.​11.​071 CrossRefPubMed
2.
Zurück zum Zitat Barr CS, Naas A, Freeman M, Lang CC, Struthers AD (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343:327–329CrossRefPubMed Barr CS, Naas A, Freeman M, Lang CC, Struthers AD (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343:327–329CrossRefPubMed
3.
Zurück zum Zitat Chenard AA, Becane HM, Tertrain F, de Kermadec JM, Weiss YA (1993) Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance, and prognosis. Neuromuscul Disord 3:201–206CrossRefPubMed Chenard AA, Becane HM, Tertrain F, de Kermadec JM, Weiss YA (1993) Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance, and prognosis. Neuromuscul Disord 3:201–206CrossRefPubMed
4.
Zurück zum Zitat Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89:838–841CrossRefPubMed Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89:838–841CrossRefPubMed
5.
Zurück zum Zitat Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 12:926–929CrossRefPubMed Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 12:926–929CrossRefPubMed
6.
Zurück zum Zitat Finsterer J, Stollberger C (2003) The heart in human dystrophinopathies. Cardiology 99:1–19 68446CrossRefPubMed Finsterer J, Stollberger C (2003) The heart in human dystrophinopathies. Cardiology 99:1–19 68446CrossRefPubMed
7.
Zurück zum Zitat Frankel KA, Rosser RJ (1976) The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 7:375–386CrossRefPubMed Frankel KA, Rosser RJ (1976) The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 7:375–386CrossRefPubMed
8.
Zurück zum Zitat Goldberg SJ, Stern LZ, Feldman L, Allen HD, Sahn DJ, Valdes-Cruz LM (1982) Serial two-dimensional echocardiography in Duchenne muscular dystrophy. Neurology 32:1101–1105CrossRefPubMed Goldberg SJ, Stern LZ, Feldman L, Allen HD, Sahn DJ, Valdes-Cruz LM (1982) Serial two-dimensional echocardiography in Duchenne muscular dystrophy. Neurology 32:1101–1105CrossRefPubMed
11.
Zurück zum Zitat Linker NJ, Colonna P, Kekwick CA, Till J, Camm AJ, Ward DE (1992) Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 69:634–638CrossRefPubMed Linker NJ, Colonna P, Kekwick CA, Till J, Camm AJ, Ward DE (1992) Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 69:634–638CrossRefPubMed
12.
Zurück zum Zitat Malik M, Batchvarov VN (2000) Measurement, interpretation, and clinical potential of QT dispersion. J Am Coll Cardiol 36:1749–1766CrossRefPubMed Malik M, Batchvarov VN (2000) Measurement, interpretation, and clinical potential of QT dispersion. J Am Coll Cardiol 36:1749–1766CrossRefPubMed
13.
Zurück zum Zitat Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260–2264. doi:10.1016/j.jacc.2004.03.035 CrossRefPubMed Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43:2260–2264. doi:10.​1016/​j.​jacc.​2004.​03.​035 CrossRefPubMed
14.
Zurück zum Zitat Moon JC, Mogensen J, Elliott PM, Smith GC, Elkington AG, Prasad SK, Pennell DJ, McKenna WJ (2005) Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 91:1036–1040. doi:10.1136/hrt.2004.041384 PubMedCentralCrossRefPubMed Moon JC, Mogensen J, Elliott PM, Smith GC, Elkington AG, Prasad SK, Pennell DJ, McKenna WJ (2005) Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 91:1036–1040. doi:10.​1136/​hrt.​2004.​041384 PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271–277CrossRefPubMed Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271–277CrossRefPubMed
16.
Zurück zum Zitat O’Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874. doi:10.1016/j.jacc.2010.05.010 CrossRefPubMed O’Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874. doi:10.​1016/​j.​jacc.​2010.​05.​010 CrossRefPubMed
17.
Zurück zum Zitat Perloff JK (1984) Cardiac rhythm and conduction in Duchenne’s muscular dystrophy: a prospective study of 20 patients. J Am Coll Cardiol 3:1263–1268CrossRefPubMed Perloff JK (1984) Cardiac rhythm and conduction in Duchenne’s muscular dystrophy: a prospective study of 20 patients. J Am Coll Cardiol 3:1263–1268CrossRefPubMed
18.
Zurück zum Zitat Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, Takeda S, Wilton SD, Wolff JA, Wooddell CI, Xiao X, Tremblay JP (2011) Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther 19:830–840. doi:10.1038/mt.2011.59 PubMedCentralCrossRefPubMed Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, Takeda S, Wilton SD, Wolff JA, Wooddell CI, Xiao X, Tremblay JP (2011) Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther 19:830–840. doi:10.​1038/​mt.​2011.​59 PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Politano L, Nigro G (2012) Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results. Acta Myol 31:24–30PubMedCentralPubMed Politano L, Nigro G (2012) Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results. Acta Myol 31:24–30PubMedCentralPubMed
20.
Zurück zum Zitat Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E, Gottliebson WM (2009) Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovas Imag 25:57–63. doi:10.1007/s10554-008-9352-y CrossRef Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E, Gottliebson WM (2009) Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovas Imag 25:57–63. doi:10.​1007/​s10554-008-9352-y CrossRef
21.
Zurück zum Zitat Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49:1874–1879. doi:10.1016/j.jacc.2006.10.078 CrossRefPubMed Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49:1874–1879. doi:10.​1016/​j.​jacc.​2006.​10.​078 CrossRefPubMed
22.
Zurück zum Zitat Towbin JA (1998) The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol 10:131–139CrossRefPubMed Towbin JA (1998) The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol 10:131–139CrossRefPubMed
23.
Zurück zum Zitat van de Loo A, Arendts W, Hohnloser SH (1994) Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects. Am J Cardiol 74:1113–1118CrossRefPubMed van de Loo A, Arendts W, Hohnloser SH (1994) Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects. Am J Cardiol 74:1113–1118CrossRefPubMed
24.
Zurück zum Zitat Wilson JM, Villareal RP, Hariharan R, Massumi A, Muthupillai R, Flamm SD (2002) Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J 29:176–180PubMedCentralPubMed Wilson JM, Villareal RP, Hariharan R, Massumi A, Muthupillai R, Flamm SD (2002) Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. Tex Heart Inst J 29:176–180PubMedCentralPubMed
25.
Zurück zum Zitat Yanagisawa A, Miyagawa M, Yotsukura M, Tsuya T, Shirato C, Ishihara T, Aoyagi T, Ishikawa K (1992) The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy. Am Heart J 124:1244–1250CrossRefPubMed Yanagisawa A, Miyagawa M, Yotsukura M, Tsuya T, Shirato C, Ishihara T, Aoyagi T, Ishikawa K (1992) The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy. Am Heart J 124:1244–1250CrossRefPubMed
26.
Zurück zum Zitat Yotsukura M, Yamamoto A, Kajiwara T, Nishimura T, Sakata K, Ishihara T, Ishikawa K (1999) QT dispersion in patients with Duchenne-type progressive muscular dystrophy. Am Heart J 137(4 Pt 1):672–677CrossRefPubMed Yotsukura M, Yamamoto A, Kajiwara T, Nishimura T, Sakata K, Ishihara T, Ishikawa K (1999) QT dispersion in patients with Duchenne-type progressive muscular dystrophy. Am Heart J 137(4 Pt 1):672–677CrossRefPubMed
Metadaten
Titel
Predictive Value of Myocardial Delayed Enhancement in Duchenne Muscular Dystrophy
verfasst von
Shaji C. Menon
Susan P. Etheridge
Kirk N. Liesemer
Richard V. Williams
Tyler Bardsley
Mason C. Heywood
Michael D. Puchalski
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2014
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-014-0929-z

Weitere Artikel der Ausgabe 7/2014

Pediatric Cardiology 7/2014 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.